Business

Viral Vector Manufacturing Market 2019-2024 by Size, Growth, Vendors, Trends, Challenges, Drivers, and Technology Leadership

Viral Vector Manufacturing

This “Viral Vector Manufacturing Market” report provides a detailed study on market and how it is impacting the industry. The report includes details of emerging trends, growth history, sales channel, manufacturers profiled in business, market share of product, application and regional scope of industry. In addition, the report also mentions opportunities that manufacturers operating in the global Viral Vector Manufacturing market can use for expanding their business in untapped market to increase their customer base.

Request a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14099017

Market Overview:

  • The viral vector manufacturing market is expected to register a CAGR of 19% over the forecast period. Certain factors that are driving the market include the rising prevalence of genetic disorders, cancer, and infectious diseases, the increasing number of clinical studies, and availability of funding for gene therapy development, and potential applications in novel drug delivery approaches.
  • Currently, several viral vector-based drugs have been approved. For instance, Gendicine™, the first gene therapy drug uses an oncolytic adenovirus vector, GlyberaRR (Alipogene tiparvovec) is a recombinant AAV product for lipoprotein lipase deficiency, and StrimvelisR which is a lentivirus vector for severe combined immunodeficiency (SCID) was approved in Europe. Furthermore, the second-generation oncolytic herpes simplex virus-1 expressing GM-CSF (Granulocyte-macrophage colony-stimulating factor) was recently approved for melanoma treatment in Europe and the United States, under the name T-vec (talimogene laherparepvec). Furthermore, there are significant government initiatives for the development of precision and personalized medicine in place, which are supplementing the R&D activities of academia and the industry. The government initiatives are driving the market’s growth through direct funding, increasing awareness, and streamlining the regulatory environment via changes, such as fast track approval processes.
  • Hence, owing to the availability of funding, the market for viral vector manufacturing is expected to grow in the future.

    Viral Vector Manufacturing Market Covers Manufacturers:

  • Cobra Biologics
  • Finvector Oy
  • Fujifilm Diosynth Biotechnologies U.S.A., Inc.
  • Kaneka Corporation (Eurogentec)
  • Merck KGaA
  • Novasep Inc.
  • Oxford BioMedica Plc.
  • Sanofi SA
  • Spark Therapeutics Inc.
  • Thermo Fisher Scientific Inc.

    Scope of the Report:

  • As per the scope of this report, viral vectors represent one of the primary tools that can be used to deliver genetic material into cells. Viral vectors can be utilized in gene therapy, for the treatment of different diseases, such as heart defects, metabolic diseases, cancers, and neurodegenerative disorders. Viral vectors that are based on adenoviruses, adeno-associated viruses, lentiviruses, retroviruses, herpes simplex viruses, and baculovirus, among others, are being routinely used in life science research, and are finding their applications in vaccinology and novel drug delivery approaches.
  • The report gives a detailed analysis of the types of viral vectors, the diseases it deals with, and its applications along with the geographical considerations.

    For More Information or Query or Customization Before Buying, Visit at @ https://www.industryresearch.co/enquiry/pre-order-enquiry/14099017

    Key Market Trends:

    The Cancer Sub-segment is Expected to Grow Faster in the Disease Segment

    In the field of oncology, viral vector-based gene therapy has demonstrated steady progress. A multitude of viral vectors has been engineered for both therapeutic and preventive applications, in cancers. A critical development in viral vector-based cancer therapy has been the application of engineered and naturally occurring oncolytic viral vectors. These vectors are programmed to specifically replicate inside the cancer cells and induce toxic effects, which ultimately results in apoptosis. The attractive features of viral vectors relate to their capability to provide high levels of transgene expression, in a broad range of host cells.

    The high demand for effective therapeutics for the management of cancers, the presence of fast track approval process, and the prospects of novel drugs to turn into blockbuster products are primary reasons responsible for the significant R&D investments in the field of viral vector-based cancer therapeutics, which, in turn, is driving the market’s growth.

    North America Dominates the Market and is Expected to Follow the Same Trend in the Future As Well

    North America currently dominates the market for viral vector manufacturing and is expected to continue its stronghold for a few more years. The United States holds the largest market share in the North American region owing to factors, such as the high adoption rate of new therapies and high awareness of the general population. The increasing prevalence of genetic and chronic disorders, such as cancer, an aging population, growing demand for targeted and personalized medicine, and favorable government initiatives are the factors responsible for the significant market size in the United States.

    Purchase this Report (Price 4250 USD for single user license) https://www.industryresearch.co/purchase/14099017

    Target Audience of Viral Vector Manufacturing Market:

    • Manufacturer / Potential Investors
    • Traders, Distributors, Wholesalers, Retailers, Importers and Exporters.
    • Association and government bodies.

    Key Reasons to Viral Vector Manufacturing Market Report:

    • Analyzing various perspectives of the Viral Vector Manufacturing market with the help of Porter’s five forces analysis
    • The End User that is expected to dominate the Viral Vector Manufacturing market is analyzed in detail
    • The regions which are expected to witness fastest growth during the forecast period are analyzed and estimated for growth of Viral Vector Manufacturing market.
    • Identify the latest developments, market shares and strategies employed by the major market players.
    • Regional analysis of Viral Vector Manufacturing market studied, during the forecast period
    • The segments that are expected to dominate the Viral Vector Manufacturing market studied.

    About Industry Research:

    Industry Research is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in-depth market research. We are one of the top report resellers in the market, dedicated to bringing you an ingenious concoction of data parameters.

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Report: Aromatics Market 2019-2025 Leading Countries with Global Growth Rate, Industry Size, Price, Revenue, Share, Latest Trends, and Forecast

  • Related Articles

    Close